Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujimoto, J.
Right arrow Articles by Tamaya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimoto, J.
Right arrow Articles by Tamaya, T.
[Cancer Research 60, 3662-3665, July 1, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

The Value of Platelet-derived Endothelial Cell Growth Factor as a Novel Predictor of Advancement of Uterine Cervical Cancers

Jiro Fujimoto1, Hideki Sakaguchi, Ikumi Aoki and Teruhiko Tamaya

Department of Obstetrics and Gynecology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu City 500-8705, Japan

Serum platelet-derived endothelial cell growth factor (PD-ECGF) in patients with uterine cervical cancers revealed a significantly positive correlation with clinical stage and tumor size and with the advancement indicators lymph node metastasis, parametrial involvement, and vessel permeation in both squamous cell carcinomas and adenocarcinomas. The prognosis of the patients with high serum PD-ECGF was extremely poor, whereas the 36-month survival rate of the other patients with low serum PD-ECGF was 81.3% in squamous cell carcinomas and 80.0% in adenocarcinomas. Our data indicate that serum PD-ECGF levels reflect the status of advancement of uterine cervical cancers and thus may be recognized as a novel tumor marker for both squamous cell carcinomas and adenocarcinomas of the uterine cervix.




This article has been cited by other articles:


Home page
Anticancer ResHome page
J. FUJIMOTO
Novel Strategy of Anti-angiogenic Therapy for Uterine Cervical Carcinomas
Anticancer Res, July 1, 2009; 29(7): 2665 - 2669.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
H. Toyoki, J. Fujimoto, E. Sato, H. Sakaguchi, and T. Tamaya
Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers
Ann. Onc., January 1, 2005; 16(1): 51 - 55.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Fujimoto, I. Aoki, H. Toyoki, S. Khatun, and T. Tamaya
Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers
Ann. Onc., October 1, 2002; 13(10): 1598 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Fujimoto, I. Aoki, H. Toyoki, S. Khatun, and T. Tamaya
Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers
Ann. Onc., October 1, 2002; 13(10): 1605 - 1611.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Yao, T. Kubota, K. Sato, and R. Kitai
Macrophage Infiltration-associated Thymidine Phosphorylase Expression Correlates with Increased Microvessel Density and Poor Prognosis in Astrocytic Tumors
Clin. Cancer Res., December 1, 2001; 7(12): 4021 - 4026.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.